1. Home
  2. FKWL vs INMB Comparison

FKWL vs INMB Comparison

Compare FKWL & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Wireless Corp.

FKWL

Franklin Wireless Corp.

HOLD

Current Price

$4.44

Market Cap

53.7M

Sector

Utilities

ML Signal

HOLD

Logo INmune Bio Inc. Common stock

INMB

INmune Bio Inc. Common stock

HOLD

Current Price

$1.74

Market Cap

49.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FKWL
INMB
Founded
1981
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.7M
49.2M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
FKWL
INMB
Price
$4.44
$1.74
Analyst Decision
Strong Buy
Hold
Analyst Count
1
3
Target Price
$6.00
$4.30
AVG Volume (30 Days)
9.7K
393.0K
Earning Date
11-14-2025
10-30-2025
Dividend Yield
0.91%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$45,508,949.00
$50,000.00
Revenue This Year
N/A
$191.43
Revenue Next Year
$13.49
$12,299.51
P/E Ratio
N/A
N/A
Revenue Growth
32.05
19.05
52 Week Low
$3.67
$1.38
52 Week High
$7.45
$11.64

Technical Indicators

Market Signals
Indicator
FKWL
INMB
Relative Strength Index (RSI) 38.49 56.83
Support Level $4.35 $1.53
Resistance Level $4.62 $1.75
Average True Range (ATR) 0.21 0.12
MACD -0.04 0.04
Stochastic Oscillator 22.54 92.68

Price Performance

Historical Comparison
FKWL
INMB

About FKWL Franklin Wireless Corp.

Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.

About INMB INmune Bio Inc. Common stock

INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.

Share on Social Networks: